Vancomycin-resistant enterococcal bloodstream infections on a hematopoietic stem cell transplant unit: Are the sick getting sicker?

Bone Marrow Transplantation

Volumn 38, Issue 12, 2006, Pages 813-819

  Dubberke, E R ^a   Hollands, J M ^b   Georgantopoulos, P ^a   Augustin, K ^b   DiPersio, J F ^a   Mundy, L M ^c,d   Khoury, H J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

^c SAINT LOUIS UNIVERSITY   (United States)

^d Jonathan Lax Treatment Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIFUNGAL AGENT; CHLORAMPHENICOL; DALFOPRISTIN PLUS QUINUPRISTIN; GENTAMICIN; LINEZOLID; STREPTOMYCIN; VANCOMYCIN;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LEUKEMIA; ADULT; AGED; APACHE; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BACTEREMIA; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC LEUKEMIA; COHORT ANALYSIS; DATA ANALYSIS; DEATH; DRUG MEGADOSE; DRUG USE; FEMALE; GRAFT RECIPIENT; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HOSPITAL DEPARTMENT; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; SURVIVAL TIME; UNITED STATES; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ADULT; AGED; APACHE; ENTEROCOCCUS; FEMALE; GRAFT VS HOST DISEASE; GRAM-POSITIVE BACTERIAL INFECTIONS; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; VANCOMYCIN RESISTANCE;

EID: 33751543323     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705530     Document Type: Article

References (29)

1. Fainstein V, Rodriguez V, Turck M, Hermann G, Rosenbaum B, Bodey GP. Patterns of oropharyngeal and fecal flora in patients with acute leukemia. J Infect Dis 1981; 144: 10-18.
2. Schimpff SC, Young VM, Greene WH, Vermeulen GD, Moody MR, Wiernik PH. Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens. Ann Intern Med 1972; 77: 707-714.
3. Schimpff SC. Infections in cancer patients: Differences between developed and less developed countries? Eur J Cancer 1991; 27: 407-408.
4. Schimpff SC. Gram-negative bacteremia. Support Care Cancer 1993; 1: 5-18.
5. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: A meta-analysis. Clin Infect Dis 2003; 36: 53-59.
6. Kaye D. Enterococci. Biologic and epidemiologic characteristics and in vitro susceptibility. Arch Intern Med 1982; 142: 2006-2009.
7. Low DE, Keller N, Barth A, Jones RN. Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001; 32 (Suppl 2): S133-S145.
8. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991; 91: 72S-75S.
9. Treitman AN, Yarnold PR, Warren J, Noskin GA. Emerging incidence of Enterococcus faecium among hospital isolates (1993 to 2002). J Clin Microbiol 2005; 43: 462-463.
10. Handwerger S, Raucher B, Altarac D, Monka J, Marchione S, Singh KV et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis 1993; 16: 750-755.
11. Wells VD, Wong ES, Murray BE, Coudron PE, Williams DS, Markowitz SM. Infections due to beta-lactamase-producing, high-level gentamicin-resistant Enterococcus faecalis. Ann Intern Med 1992; 116: 285-292.
12. Zaas AK, Song X, Tucker P, Perl TM. Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci. Clin Infect Dis 2002; 35: 1139-1146.
13. Safdar N, Maki DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 2002; 136: 834-844.
14. Edmond MB, Ober JF, Dawson JD, Weinbaum DL, Wenzel RP. Vancomycin-resistant enterococcal bacteremia: Natural history and attributable mortality. Clin Infect Dis 1996; 23: 1234-1239.
15. Shay DK, Maloney SA, Montecalvo M, Banerjee S, Wormser GP, Arduino MJ et al. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis 1995; 172: 993-1000.
16. Lucas GM, Lechtzin N, Puryear DW, Yau LL, Flexner CW, Moore RD. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes. Clin Infect Dis 1998; 26: 1127-1133.
17. Garbutt JM, Ventrapragada M, Littenberg B, Mundy LM. Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia. Clin Infect Dis 2000; 30: 466-472.
18. Lautenbach E, Bilker WB, Brennan PJ. Enterococcal bacteremia: Risk factors for vancomycin resistance and predictors of mortality. Infect Control Hosp Epidemiol 1999; 20: 318-323.
19. Linden PK, Pasculle AW, Manez R, Kramer DJ, Fung JJ, Pinna AD et al. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. Clin Infect Dis 1996; 22: 663-670.
20. DiazGranados CA, Jernigan JA. Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection. J Infect Dis 2005; 191: 588-595.
21. Small TN, Boulad F, Papadopoulos E, Jaffe D, O'Reilly R, Sepkowitz K et al. Incidence and outcome of vancomycin-resistant enterococcal bacteremia following allogeneic hematopoietic stem cell transplant (HSCT). In: Program and abstracts of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (San Diego). American Society for Microbiology: Washington, DC, 2002, p 325.
22. Avery R, Kalaycio M, Pohlman B, Sobecks R, Kuczkowski E, Andresen S et al. Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course. Bone Marrow Transplant 2005; 35: 497-499.
23. Puzniak LA, Mayfield J, Leet T, Kollef M, Mundy LM. Acquisition of vancomycin-resistant enterococci during scheduled antimicrobial rotation in an intensive care unit. Clin Infect Dis 2001; 33: 151-157.
24. Horan TC, Emori TG. Definitions of key terms used in the NNIS System. Am J Infect Control 1997; 25: 112-116.
25. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295-304.
26. Rowlings PA, Przepiorka D, Klein JP, Gale RP, Passweg JR, Henslee-Downey PJ et al. IBMTR Severity Index for grading acute graft-versus-host disease: Retrospective comparison with Glucksberg grade. Br J Haematol 1997; 97: 855-864.
27. Moellering RC. Enterococcus Species, Streptococcus bovis, and Leuconostoc Species. In: Mandell GL, Bennett JE, Dolin R (eds). Principles and Practice of Infectious Diseases, Sixth edn. Elsevier Churchill-Livingstone: Philadelphia, 2005, pp 2411-2421.
28. Lodise TP, McKinnon PS, Tam VH, Rybak MJ. Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma center. Clin Infect Dis 2002; 34: 922-929.
29. Bhavnani SM, Drake JA, Forrest A, Deinhart JA, Jones RN, Biedenbach DJ et al. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia. Diagn Microbiol Infect Dis 2000; 36: 145-158